Mycophenolate vs Azathioprin in Autoimmune Hepatitis

This study has been completed.
Sponsor:
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00687180
First received: May 28, 2008
Last updated: May 29, 2008
Last verified: May 2008
  Purpose

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.


Condition Intervention Phase
Autoimmune Hepatitis
Drug: Treatment with mycophenolat mofetil
Drug: Treatment with azathioprin
Phase 4

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Rigshospitalet, Denmark:

Arms Assigned Interventions
Active Comparator: I
MMF
Drug: Treatment with mycophenolat mofetil
Active Comparator: II Drug: Treatment with azathioprin

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • De novo autoimmune hepatitis
  • Consent

Exclusion Criteria:

  • age below 18
  • pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00687180

Locations
Denmark
Rigshospitalet, Dept. of Hepatology A-2121
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
  More Information

No publications provided

Responsible Party: Bent Hansen, Chief of Dept. of Hepatology A-2121, Rigshospitalet, Denmark
ClinicalTrials.gov Identifier: NCT00687180     History of Changes
Other Study ID Numbers: MMF vs Imurel
Study First Received: May 28, 2008
Last Updated: May 29, 2008
Health Authority: Denmark: Ethics Committee
Denmark: National Board of Health

Keywords provided by Rigshospitalet, Denmark:
Prednisolone dosage

Additional relevant MeSH terms:
Hepatitis, Autoimmune
Hepatitis
Hepatitis A
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Hepatitis, Chronic
Autoimmune Diseases
Immune System Diseases

ClinicalTrials.gov processed this record on July 22, 2014